| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10813727 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 2770 journal articles in the PubMed database | Email to a friend | | |
| Montoto S, Camós M, López-Guillermo A, et al.
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease. [Journal Article]
Cancer 2000 May 1; 88(9):2142-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Salvagno L, Sorarù M, Sotti G, et al.
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease. [Journal Article]
Ann Oncol 1995 Feb; 6(2):173-9.
Abstract | Full Citation | Find Related Articles | | Hamilton VM, Norris C, Bunin N, et al.
Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease. [Clinical Trial, Journal Article]
J Pediatr Hematol Oncol 2001 Feb; 23(2):84-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Connors JM, Klimo P, Adams G, et al.
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Oncol 1997 Apr; 15(4):1638-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Glick JH, Young ML, Harrington D, et al.
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial. [Clinical Trial, Journal Article, Randomized Controlled Trial]
J Clin Oncol 1998 Jan; 16(1):19-26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Arranz R, Gil-Fernández JJ, Muñoz E, et al.
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center] [Journal Article, Review]
Sangre (Barc) 1998 Jun; 43(3):179-84.
Abstract | Full Citation | Find Related Articles | | O'Reilly SE, Hoskins P, Klimo P, et al.
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease. [Journal Article]
Ann Oncol 1991 Jan.:17-23.
Abstract | Full Citation | Find Related Articles | | Klimo P, Connors JM
An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program. [Journal Article]
Semin Hematol 1988 Apr; 25(2 Suppl 2):34-40.
Abstract | Full Citation | Find Related Articles | | Duggan DB, Petroni GR, Johnson JL, et al.
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Oncol 2003 Feb 15; 21(4):607-14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
